Table 1 Comparison of studies on controlled ovarian stimulation with FSH in recent studies of the last 10 years.
Reference | Study | FSH starting dose for PCOS | Recommendation for dose adjustment |
---|---|---|---|
Palep-Singh et al., 2007 | Observational comparative study (PCOS in Asian women n = 104, Caucasian n = 220, controls n = 284) | Mean starting dose150 IU for Asian PCOS200 IU for Caucasian PCOS225 IU for Asian and Caucasian tubal infertility | Adjustment according to age, basal FSH and BMI, after 7 days possible increase of dosage in case of suboptimal response |
Weghofer et al., 2007 | Retrospective cohort study of 47 women with PCOS compared to 100 controls | 150–450 IU for PCOS and Non-PCOS | Adjustment to follicular response |
Koundouros et al., 2008 | Prospective randomized study with PCOS-patients (n = 225) | 75 IU/d step up225 IU/d step down150 IU and individual adjustment | Step-up regimen: 75 IU/d for 6 days, then increase of 37.5 IUStep-down: 225 IU/d of FSH for the first 3 days followed, then decrease to 150 IU/d for the next 3 days, then decreased to 75 IU/d or sustain at 150 IUStep-up/Step-down: 150 IU on day 1, then decrease to 75 IU on day 2, then increase back to 150 IU and so on until day 6, then, sustain at 150 IU/d or 75 IU/d |
Sahu et al., 2008 | Retrospective analysis of 51 PCOS ART-cycles, compared to 50 cycles with ultrasound morphology of PCO, control group 104 cycles | 300 IU | According ovarian reserve score (age, BMI, AFC, FSH, E2), control on day 4 |
Swanton et al., 2010 | Prospective cohort study (n = 290 women, including PCOS n = 78, PCO n = 101 and control n = 101) | 150–375 IU according to age, basal FSH and previous ovarian response to gonadotropins – no difference in PCOS, PCO | No adjustment described |
Ashrafi et al., 2011 | Controlled randomized prospective study with n = 90 women with PCOS – three protocol variations concerning type of gonadotropins given and dose adjustment | 150 IU for PCOS in all groups | Fixed dose of 150 IEStep down protocol to 75 IU, when leading follicle reached 14 mm in diameterFSH discontinued and low dose HCG when leading follicle 14 mm |
Decanter et al., 2013 | Single center prospective non-randomized interventional study (n = 113). Intervention was pretreatment with oral contraceptives | 100 to 200 IU, according to age, BMI and AFC | No adjustment described |
Huber et al., 2013 | Retrospective cross-sectional study with n = 7 520 cycles, mixed cohort, no recommendation for PCOS | Mixed cohort, 75–450 IU; 75–125 IE for expected high response, 150–225 IU for normal response300–450 IU for poor response, according to age, markers of ovarian reserve, BMI, and previous response | Individual adjustment to responseNo recommendation for PCOS |
Figen Turkcapar et al., 2013 | Prospective randomized controlled study (n = 80 women with PCOS), HMG vs. FSH stimulation | 150 IU | Adjustment according to E2, sonographical response |
Akpinar et al., 2014 | Retrospective observational study of n = 337 cycles of women with PCOS | 75–300 IU according to BMI | No adjustment described |
Shi et al., 2014 | Multicenter prospective randomized controlled study of 1 180 women with PCOS. Intervention randomized in fresh ET at day 3 or freeze all | 112.5 IU/day for patients ≤ 60 kg for PCOS150 IU/day for patients > 60 kg for PCOS | Adjustment according to ovarian response |